Bareš Martin ( search by name in IS MU /auth )

Body na spoluautora Body za publikaci pro MU Odkaz ISVaV
2,81 2,81 Léčba dystonií
14,45 43,35 Long-term assessment of the efficacy and tolerability of botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy: comparison of dosing frequency.
1,40 2,81 Patologické hráčství u pacientů s Parkinsonovou nemocí
0,00 0,00 Cerebellum contributes to motor timing and prediction. Behavioral and fMRI study in healthy subjects and patients with spinocerebellar ataxia.
0,00 0,00 Cerebellum contributes to motor timing and prediction.
6,39 51,12 Cognitive- and Movement- Related Potentials Recorded in the Human basal ganglia.
8,58 25,75 Cognitive functioning after repetitive transcranial magnetic stimulation in patients with cerebrovascular disease without dementia: a pilot study of seven patients.
8,16 32,63 Heart valve abnormalities in Parkinson's disease treated with dopamine agonists.
42,43 169,70 Functional coupling between anterior prefrontal cortex (BA10) and hand muscle contraction during intentional and imitative motor acts.
0,00 0,00 Update on spinocerebellar ataxias
4,45 22,24 The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial
2,40 12,00 The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: Results of an open, prospective, six months and one-year follow-up
0,00 0,00 Pregradual and Postgradual Medical System in the USA
0,00 0,00 The effect of response type (motor output versus mental counting) on the intracerebral distribution of the slow cortical potentials in an externally cued (Contingent negative Variation) paradigm
3,14 12,56 Cognitive performance in people with Parkinson's disease and mild or moderate depression: effects of dopamine agonists in an add-on to L-dopa therapy.
0,00 0,00 The effect of response type on the intracerebral distribution of the slow cortical potentials in contingent negative variation paradigm
8,57 34,27 Cognitive performance in people with Parkinson's disease and mild or moderate depression: effects of dopamine agonists in an add-on to L-dopa therapy.
2,34 14,02 Dropped head syndrome in severe intractable epilepsies with mental retardation.
2,09 12,56 Dropped head syndrome in severe intractable epilepsies with mental retardation.
0,00 0,00 Myoklonus – srovnání účinnosti léčby podle typu ovlivněných neurotransmiterových systémů
2,81 2,81 "Pozdní hybné komplikace Parkinsonovy nemoci
2,81 2,81 Novinky v transkraniální magnetické stimulaci
1,40 2,81 Účasť cerebella na kognitívnych a nemotorických funkciách v obraze funkčnej magnetickej rezonancie
6,90 20,69 Disturbed intracortical excitability in early Parkinson's disease is l-DOPA dose related: A prospective 12-month paired TMS study.
6,90 20,69 Cognitive potentials in the basal ganglia.
4,79 14,38 The effect of response type (motor output versus mental counting) on the intracerebral distribution of the slow cortical potentials in an externally cued (CNV) paradigm.
0,94 2,81 Dlouhodobá léčba spasticity dolních a horních končetin botulotoxinem A u dětí s dětskou mozkovou obrnou: Retrospektivní studie.
3,99 23,91 Effects of ropinirole on nonmotor symptoms of early and advanced Parkinson disease: a prospective multicentre study.
76,25 305,00 Directional Functional Coupling of Cerebral Rhythms Between Anterior Cingulate and Dorsolateral Prefrontal Areas During Rare Stimuli: A Directed Transfer Function Analysis of Human Depth EEG Signal.
4,00 12,01 Deep brain stimulation in acute management of status dystonicus.
8,07 40,34 Modifications of cognitive and motor tasks affect the occurrence of event-related potentials in the human cortex.
0,00 0,00 Onemocnění mozečku
7,50 22,51 Recurrent Miller Fisher syndrome with abnormal neuromuscular transmission: a case report.
0,00 0,00 Suppression of L-dopa induced dyskinesias in advanced Parkinson's disease by continuous subcutaneous infusions of apomorphine results of a two year, prospective follow-up
0,00 0,00 Využitie botulotoxínu v terapii sialorrhei u Parkinsonovej choroby
Back
(c) Michal Bulant, 2011